Diabetes is associated with increased liver cancer incidence and mortality in adults: A report from Asia Cohort Consortium
- PMID: 38661292
- DOI: 10.1002/ijc.34965
Diabetes is associated with increased liver cancer incidence and mortality in adults: A report from Asia Cohort Consortium
Abstract
There has been growing evidence suggesting that diabetes may be associated with increased liver cancer risk. However, studies conducted in Asian countries are limited. This project considered data of 968,738 adults pooled from 20 cohort studies of Asia Cohort Consortium to examine the association between baseline diabetes and liver cancer incidence and mortality. Cox proportional hazard model and competing risk approach was used for pooled data. Two-stage meta-analysis across studies was also done. There were 839,194 subjects with valid data regarding liver cancer incidence (5654 liver cancer cases [48.29/100,000 person-years]), follow-up time and baseline diabetes (44,781 with diabetes [5.3%]). There were 747,198 subjects with valid data regarding liver cancer mortality (5020 liver cancer deaths [44.03/100,000 person-years]), follow-up time and baseline diabetes (43,243 with diabetes [5.8%]). Hazard ratio (HR) (95% confidence interval [95%CI]) of liver cancer diagnosis in those with vs. without baseline diabetes was 1.97 (1.79, 2.16) (p < .0001) after adjusting for baseline age, gender, body mass index, tobacco smoking, alcohol use, and heterogeneity across studies (n = 586,072; events = 4620). Baseline diabetes was associated with increased cumulative incidence of death due to liver cancer (adjusted HR (95%CI) = 1.97 (1.79, 2.18); p < .0001) (n = 595,193; events = 4110). A two-stage meta-analytic approach showed similar results. This paper adds important population-based evidence to current literature regarding the increased incidence and mortality of liver cancer in adults with diabetes. The analysis of data pooled from 20 studies of different Asian countries and the meta-analysis across studies with large number of subjects makes the results robust.
Keywords: Asia Cohort Consortium; diabetes; incidence; liver cancer; mortality.
© 2024 UICC.
References
REFERENCES
-
- Ramachandran A. Trends in prevalence of diabetes in Asian countries. World J Diabetes. 2012;3(6):110.
-
- Jayawardena R, Ranasinghe P, Byrne NM, Soares MJ, Katulanda P, Hills AP. Prevalence and trends of the diabetes epidemic in South Asia: a systematic review and meta‐analysis. BMC Public Health. 2012;12(1):380.
-
- Kakar ZA, Siddiqui MA, Amin R, et al. Prevalence and risk factors of diabetes in adult population of South Asia. Clin Med Diagn. 2013;3(2):18‐28.
-
- Nathan DM. Diabetes: advances in diagnosis and treatment. JAMA [Internet]. 2015;314(10):1052. doi:10.1001/jama.2015.9536
-
- Lam EKK, Batty GD, Huxley RR, et al. Associations of diabetes mellitus with site‐specific cancer mortality in the Asia‐Pacific region. Ann Oncol. 2011;22(3):730‐738.
Publication types
MeSH terms
Grants and funding
- UM1CA173640/Shanghai Men's Health Study (SMHS): The US National Cancer Institute
- C20/A5860/Cancer Research UK Manchester Centre
- Singapore Chinese Health Study: The US National Cancer Institute
- 81/15/Golestan Cohort Study: Tehran University of Medical Sciences
- 2016R1A2B4014552/Korean Multicenter Cancer Cohort (KMCC): the National Research Foundation of Korea (NRF) grant funded by the Korea government
- Pars Cohort Study (PCS): Shiraz university of Medical Sciences Shiraz Iran, Digestive Diseases Research Institute (DDRI), Tehran University of Medical Sciences, Tehran, Iran
- 3 Prefecture Miyagi Study: National Cancer Center Research and Development Fund
- UM1CA182910/Shanghai Women's Health Study (SWHS): The US National Cancer Institute
- Takayama Study: National Cancer Center Research and Development Fund
- Ohsaki Cohort Study: National Cancer Center Research and Development Fund
- Japan Collaborative Cohort Study (JACC): National Cancer Center Research and Development Fund, A Grant-in-Aid for Cancer Research; Grant for Health Services and Grant for Comprehensive Research on Cardiovascular and Life-Style Related Diseases from the Ministry of Health, Labour and Welfare, Japan; Grant for the Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan
- HCRI21019/The Namwon Study: Chonnam National University Hwasun Hospital Research grant
- HCRI18007-1/The Namwon Study: Chonnam National University Hwasun Hospital Research grant
- HCRI16911-1/The Namwon Study: Chonnam National University Hwasun Hospital Research grant
- 1510040/Korean National Cancer Center Cohort (KNCC): National Cancer Center Research and Development of Korea
- 1810090/Korean National Cancer Center Cohort (KNCC): National Cancer Center Research and Development of Korea
- 1910330/Korean National Cancer Center Cohort (KNCC): National Cancer Center Research and Development of Korea
- HVM18.01/Research Grant of Vinmec Healthcare System, Hanoi, Vietnam
- 23-A-31(toku)/Japan Public Health Center-based prospective Study (JPHC Study) 1 and 2: National Cancer Center Research and Development Fund (since 2011) and a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan (from 1989 to 2010)
- 26-A-2/Japan Public Health Center-based prospective Study (JPHC Study) 1 and 2: National Cancer Center Research and Development Fund (since 2011) and a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan (from 1989 to 2010)
- 29-A-4/Japan Public Health Center-based prospective Study (JPHC Study) 1 and 2: National Cancer Center Research and Development Fund (since 2011) and a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan (from 1989 to 2010)
- 2020-A-4/Japan Public Health Center-based prospective Study (JPHC Study) 1 and 2: National Cancer Center Research and Development Fund (since 2011) and a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan (from 1989 to 2010)
- The intramural research program of the NCI, NIH USA; IARC/WHO Lyon France
- Life Span Study Cohort (LSS): The Japanese Ministry of Health, Labour, and Welfare and the U.S. Department of Energy
- 30-A-15/ACC Coordinating Center: National Cancer Center Research and Development Fund
- Health Effects of Arsenic Longitudinal Study (HEALS): National Institute of Environmental Health Science
- Mumbai Cohort Study: International Agency for Research on Cancer, Lyon, France; Clinical Trials Service Unit, Oxford, UK; World Health Organization, Geneva, Switzerland
- Miyagi Cohort Study: National Cancer Center Research and Development Fund
- R01CA0403092/Shanghai Cohort Study: National Institutes for Health
- R01CA144034/Shanghai Cohort Study: National Institutes for Health
- UM1CA182876/Shanghai Cohort Study: National Institutes for Health
- 3 Prefecture Aichi Study: The Japanese Ministry of the Environment (formerly, Environment Agency)
LinkOut - more resources
Full Text Sources
Medical